HC Wainwright Has Negative Estimate for AMPX FY2028 Earnings

Key Points

• HC Wainwright cut its FY2028 EPS forecast for Amprius Technologies to $0.08 from $0.16, while maintaining a Buy rating.
• In its latest quarter, Amprius reported a loss of $0.02 per share, missing expectations of a $0.01 loss, but revenue of $39.15 million exceeded estimates of $35.80 million.
• Analyst sentiment remains broadly positive: MarketBeat reports a Moderate Buy consensus rating and an average price target of $20.50.

Amprius Technologies, Inc. (NYSE:AMPX - Free Report) - Stock analysts at HC Wainwright lowered their FY2028 earnings estimates for Amprius Technologies in a report issued on Thursday, November 12th. HC Wainwright analyst A. Dayal now anticipates that the company will post earnings per share of $0.08 for the year, down from their prior forecast of $0.16. HC Wainwright currently has a "Buy" rating on the stock. The consensus estimate for Amprius Technologies' current full-year earnings is ($0.07) per share.

Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its earnings results on Tuesday, November 10th. The company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.01). The business had revenue of $39.15 million during the quarter, compared to analyst estimates of $35.80 million. Amprius Technologies had a negative return on equity of 12.01% and a negative net margin of 29.94%. During the same quarter in the prior year, the company earned ($0.03) EPS.

Several other research analysts have also recently issued reports on the company. William Blair reaffirmed an "outperform" rating on shares of Amprius Technologies in a research report on Friday, November 6th. Canaccord Genuity Group initiated coverage on Amprius Technologies in a research report on Wednesday, October 14th. They issued a "buy" rating and a $14.00 price target for the company. Needham & Company LLC cut their price objective on shares of Amprius Technologies from $20.00 to $15.00 and set a "buy" rating on the stock in a report on Wednesday. Zacks Research upgraded shares of Amprius Technologies from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 4th. Finally, UBS Group reiterated an "outperform" rating on shares of Amprius Technologies in a report on Friday, November 6th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $20.50.

Amprius Technologies Price Performance

Shares of Amprius Technologies stock opened at $8.39 on Friday. Amprius Technologies has a 52 week low of $7.02 and a 52 week high of $24.23. The business has a 50 day moving average price of $9.04 and a 200-day moving average price of $13.20.

Insider Buying and Selling

In other Amprius Technologies news, Director Kang Sun sold 62,101 shares of the business's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $10.34, for a total value of $642,124.34. Following the transaction, the director owned 1,218,397 shares of the company's stock, valued at approximately $12,598,224.98. The trade was a 4.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Thomas Stepien sold 8,000 shares of the business's stock in a transaction on Monday, August 24th. The stock was sold at an average price of $10.03, for a total value of $80,240.00. Following the completion of the transaction, the chief executive officer directly owned 594,096 shares in the company, valued at approximately $5,958,782.88. This represents a 1.33% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 123,311 shares of company stock worth $1,272,556. 5.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On Amprius Technologies

Hedge funds and other institutional investors have recently made changes to their positions in the stock. First Trust Advisors LP grew its position in Amprius Technologies by 9.2% during the third quarter. First Trust Advisors LP now owns 1,133,210 shares of the company's stock valued at $10,969,000 after buying an additional 95,866 shares during the period. Stephens Investment Management Group LLC raised its position in Amprius Technologies by 517.1% in the third quarter. Stephens Investment Management Group LLC now owns 4,408,140 shares of the company's stock worth $42,671,000 after acquiring an additional 3,693,816 shares during the period. Voya Investment Management LLC raised its position in Amprius Technologies by 20.3% in the third quarter. Voya Investment Management LLC now owns 190,920 shares of the company's stock worth $1,848,000 after acquiring an additional 32,262 shares during the period. Teachers Retirement System of The State of Kentucky boosted its stake in Amprius Technologies by 34.3% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 45,713 shares of the company's stock valued at $443,000 after acquiring an additional 11,685 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its stake in Amprius Technologies by 192.1% in the third quarter. Russell Investments Group Ltd. now owns 592,881 shares of the company's stock valued at $5,739,000 after acquiring an additional 389,922 shares during the last quarter. 5.04% of the stock is owned by hedge funds and other institutional investors.

Recent Amprius Technologies Headlines

These are some of the AMPX headlines that stood out recently:

• Positive Sentiment: Management is pursuing better margins and expanding U.S. production, with plans for annual pouch-cell capacity of 12 million by early 2028. Higher costs and execution remain challenges. Amprius Q3 Earnings Call Highlights Margin Push and U.S. Expansion
• Negative Sentiment: The company’s quarterly loss was wider than expected: EPS was negative $0.02 versus analysts’ forecast of negative $0.01. Freight costs also pressured margins, tempering the strong revenue growth. Amprius Technologies Reports Wider Than Expected Q3 2026 Loss
• Negative Sentiment: Analysts lowered their estimates and price targets. HC Wainwright halved its FY2028 EPS forecast to $0.08 from $0.16; B. Riley cut its target to $16 from $22, and Needham reduced its target to $15 from $20. Both firms retained Buy ratings, but the revisions add near-term pressure.

Amprius Technologies Company Profile

Amprius Technologies, Inc. develops and manufactures lithium-ion batteries designed to provide high energy density and power. Its battery technology uses silicon-based anodes, an alternative to the graphite anodes commonly used in conventional lithium-ion cells. The company's products are designed for applications where low weight and high performance are important, including electric aviation, drones, aerospace, defense and other mobility markets. Amprius offers silicon-anode cells for customers developing these systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.